Skip to main content
Watch Insiders
Market intelligence
ACADHealthcare

Acadia Pharmaceuticals Inc insider activity

In the last 90 days, no corporate insiders reported open-market purchases.

SEC-reported filing activity is provided for research purposes and is not investment advice.

90-day C-suite buyers
0
90-day purchase value
$0.00
Corporate buyers
0
Latest transaction
May 26, 2026

Executive filings

Open-market transaction history

Purchase and sale summaries are ordered by the latest reported transaction date.

Open-market insider purchase and sale transactions
DateInsider nameRoleTypeSharesPriceTotal value
May 26, 2026James KiharaPRINCIPAL ACCOUNTING OFFICERSale5,401$21.18$114,393
May 4, 2026Mark C. SchneyerEVP, CHIEF FINANCIAL OFFICERSale3,506$21.79$76,396
May 4, 2026James KiharaPRINCIPAL ACCOUNTING OFFICERSale1,332$21.79$29,024